Found: 23
Select item for more details and to access through your institution.
Development and Integration of Antibody–Drug Conjugate in Non-Hodgkin Lymphoma.
- Published in:
- Current Oncology Reports, 2015, v. 17, n. 9, p. 41, doi. 10.1007/s11912-015-0466-9
- By:
- Publication type:
- Article
Tivozanib: Status of Development.
- Published in:
- Current Oncology Reports, 2015, v. 17, n. 6, p. 1, doi. 10.1007/s11912-015-0451-3
- By:
- Publication type:
- Article
Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 837, doi. 10.3390/curroncol28010081
- By:
- Publication type:
- Article
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
- Published in:
- PLoS Medicine, 2023, v. 19, n. 6, p. 1, doi. 10.1371/journal.pmed.1004157
- By:
- Publication type:
- Article
High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0139267
- By:
- Publication type:
- Article
Amitkumar Mehta on the immuno-modulating effects of targeted therapy for multiple myeloma.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 12, p. 1044
- By:
- Publication type:
- Article
Expanding access to early phase trials: the CATCH-UP.2020 experience.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 1, p. 1, doi. 10.1093/jncics/pkac087
- By:
- Publication type:
- Article
The impact of structural factors on diagnostic delay in diffuse large B‐cell lymphoma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 4, p. 1416, doi. 10.1002/cam4.2009
- By:
- Publication type:
- Article
How Do I Recommend Extended Adjuvant Hormonal Therapy?
- Published in:
- Current Treatment Options in Oncology, 2014, v. 15, n. 1, p. 55, doi. 10.1007/s11864-013-0263-3
- By:
- Publication type:
- Article
Massive pulmonary embolism and cardiopulmonary resuscitation leading to disseminated intravascular coagulation.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 825, doi. 10.1016/j.clml.2022.06.011
- By:
- Publication type:
- Article
ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S393, doi. 10.1016/S2152-2650(21)01892-9
- By:
- Publication type:
- Article
AML-430: Utility of End-of-Induction Bone Marrow Biopsy in APL Patients Treated with ATRA/ATO Regimen.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S311, doi. 10.1016/S2152-2650(21)01736-5
- By:
- Publication type:
- Article
Poster: ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S241, doi. 10.1016/S2152-2650(21)01516-0
- By:
- Publication type:
- Article
Poster: AML-430: Utility of End-of-Induction Bone Marrow Biopsy in APL Patients Treated with ATRA/ATO Regimen.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S218, doi. 10.1016/S2152-2650(21)01373-2
- By:
- Publication type:
- Article
Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00539-8
- By:
- Publication type:
- Article
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01520-7
- By:
- Publication type:
- Article
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 18, doi. 10.1002/ajh.25659
- By:
- Publication type:
- Article
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. 161, doi. 10.1002/ajh.24615
- By:
- Publication type:
- Article
Imitating the Great Imitator: The Intersection of Sarcoidosis and Hodgkin's Lymphoma A Report of Two Cases.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 33, doi. 10.1007/s11060-022-04004-9
- By:
- Publication type:
- Article